Overview

• The Court of Arbitration for Sport (CAS) is resuming its hearing on the doping case involving the Russian figure skater Kamila Valieva, who tested positive for the endurance-boosting heart medicine trimetazidine during the 2022 Winter Olympics in Beijing.
• Following the figure skating team event in 2022, no medals were allocated, with Valieva's team, which was competing as the Russian Olympic Committee, initially finishing first - the case's final decision could impact those allocations.
• Originally, the Russian Anti-Doping Agency (RUSADA) declared that Valieva bore no "fault or negligence" in the incident and the skater defended that the drug was taken unknowingly.
• RUSADA's initial ruling is being challenged by the International Olympic Committee (IOC), the International Skating Union (ISU), and RUSADA itself - the agency has since changed its stance and is now seeking a penalty for Valieva that may include a reprimand.
• The World Anti-Doping Agency (WADA) is seeking a four-year ban for Valieva that would invalidate her results from the Beijing Games, potentially denying the Russian Olympic Committee their team event gold medal.